Robert Hugin

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

Family Promise is a national movement that aims to provide every family with a home, livelihood, and the opportunity to build a better future. The non-profit company is based in Summit, NJ. The organization works in over 200 communities across 43 states to ensure that families experiencing or at risk of homelessness have a safe place to call home. Family Promise delivers innovative solutions for family homelessness, including prevention, shelter, and stabilization services. Family Promise aspires to change the future for 1 million children by 2030 through its community-based programs. The organization was founded more than 30 years ago as a local initiative in Summit, NJ, and has since served over 1 million family members.

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland.

Choose New Jersey is a privately funded 501(c)(3) nonprofit economic development organization that aims to stimulate job creation and attract capital investment to New Jersey. The non-profit company is based in Princeton, NJ. The organization markets both domestically and internationally to promote New Jersey as the best place to grow businesses. Choose New Jersey provides free, confidential assistance to guide companies in establishing operations in the state, with the support of a network of state agencies and private partners. The organization aspires to build a stronger and more prosperous New Jersey for all. Choose New Jersey was founded by Robert J. Hugin.

Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.

Celgene Ltd. engages in the development of human pharmaceuticals and agrochemicals. It focuses on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. The company was founded on June 2, 2015 and is headquartered in Uxbridge, the United Kingdom.

The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky.

Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA.